Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06632327
- Conditions
- Lung Diseases, Lung Neoplasms, Neoplasms, +8 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
NCT07584239
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT06431633
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Hospital General Universitario de Alicante Alicante, Spain
- Hospital General de Elche Elche, Alicante, Spain
- ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
- Hospital Universitari Vall d' Hebron Barcelona, Spain
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT06008730
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT06276530
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Department of Thoracic and Vascular Surgery Tenon University Hospital Paris, France
NCT06775275
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China
NCT06241807
- Conditions
- Biomarkers / Blood, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China
High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC
NCT07182708
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
NCT03824977
- Conditions
- Lung Diseases, Lung Neoplasm Malignant, Lung Neoplasms, +6 more
- Locations
-
- Boujibar , F Rouen, France